Results 171 to 180 of about 129,762 (268)
Oxygenation in acute exacerbation of interstitial lung disease:a nationwide survey. [PDF]
Artaud-Macari E +5 more
europepmc +1 more source
Abstract Aims Inflammation plays a critical role in both the development and progression of heart failure (HF), which is a leading cause of morbidity and mortality worldwide. However, the causality between specific inflammation‐related proteins and HF risk remains unclear.
Xian‐Guan Zhu +9 more
wiley +1 more source
Is Chest Imaging Alone Adequate for Diagnosing Interstitial Lung Disease in Microscopic Polyangiitis Based on the 2022 Criteria? [PDF]
Do H, Park YB, Woo A, Lee SW.
europepmc +1 more source
Abstract Background African horse sickness (AHS), caused by the vector‐borne African horse sickness virus (AHSV), is endemic to sub‐Saharan Africa and infection results in high mortality in naïve equine populations. Clinical signs include submucosal petechiae and prolonged bleeding post venepuncture indicative of hypocoagulation.
Eva Christina Schliewert +2 more
wiley +1 more source
Vascular etiologies of unilateral pulmonary fibrosis: Case series and literature overview. [PDF]
Cozzi D +7 more
europepmc +1 more source
The diagram of the mechanism of action by which UroA regulates RF. ABSTRACT The global prevalence and mortality rates associated with chronic kidney disease (CKD) have been on a continuous rise over recent decades. Renal fibrosis (RF) serves as a critical factor in the progression of CKD to end‐stage renal disease.
Xue Wu +8 more
wiley +1 more source
Pulmonary Amyloidosis as a Differential Diagnosis in Interstitial Lung Diseases. [PDF]
Cabrera-Cesar E, Garcia JL, de Pedro IP.
europepmc +1 more source
Abstract The integration of modern systemic therapies with radiotherapy (RT) represents a promising strategy in breast cancer management, enhancing both locoregional control and systemic disease outcomes. This expert consensus from the Institut Curie Breast Radiotherapy Group focuses exclusively on modern systemic agents, synthesizing current evidence ...
Cezara Cheptea +5 more
wiley +1 more source
What's New? Global research has found that for people newly diagnosed with advanced non‐small cell lung cancer (NSCLC), the anti‐PD‐1 monoclonal antibody pembrolizumab on its own often leads to better results than traditional chemotherapy. The present report details long‐term findings of pembrolizumab therapy specifically among Chinese patients.
Yi‐Long Wu +14 more
wiley +1 more source
Rituximab-Induced Interstitial Lung Disease: A Possible Underestimated Complication-A Systematic Review. [PDF]
Zamfir AS +9 more
europepmc +1 more source

